Work

Activity of sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): A phase II trial of the University of Chicago Phase II Consortium

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.10502

Authors: L. Wiebe, K. E. Kasza, R. G. Maki, D. R. D’Adamo, W. A. Chow, J. L. Wade III, E. Agamah, W. M. Stadler, E. E. Vokes, H. L. Kindler

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2487815795

Cites:

Cited by: 90

Related to: 10